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ABSTRACT
Citalopram is an antidepressant drug used to treat depression associated with mood disorders. This research introduces the
design of an ion-pair based polyvinylchloride (PVC) membrane sensor for the citalopram determination based on theoretical investigations. For the membrane preparation, citalopram-tetraphenyl borate ion-pair was employed as an electroactive material in the PVC
membrane. In parallel, several plasticizers were studied, i.e. dibutyl phthalate (DBP), acetophenon (AP), nitrobenzene (NB) and
nitrophenyloctyl ether (o-NPOE). After a series of experiments, the best electrode performance was accomplished with a membrane
composition of 30% PVC, 66% DBP, and 4% ion-pair. This electrode illustrated a fast (~5 s), stable and Nernstian response (58.6 ±
0.3 mV/decade) across a relatively wide citalopram concentration range 1×10 -5 to 1×10 -2 M and in the pH range of 3.0-5.5. Validation
of the method showed suitability of the sensors for the quality control analysis of citalopram hydrobromide in pharmaceutical formulation and urine. The proposed method was simple, accurate and precise and can be used as a detector for HPLC.
Key words: potentiometric sensor, PVC membrane, ion-pair, citalopram, Density Functional Theory, chemometrics

INTRODUCTION
Citalopram (Figure 1), 1-(3-dimethylaminopropyl)-1(4-fluorophenyl)-5-phthalan carbonitrile, is an antidepressant drug used to treat depression associated with mood
disorders. It is also used on occasion for the treatment
of body dysmorphic disorder and anxiety. Citalopram
belongs to a class of drugs known as selective serotonin
reuptake inhibitors (SSRIs). It is primarily used to treat
the symptoms of depression but can also be prescribed for
social anxiety disorder, panic disorder, obsessive-compulsive disorder, the Huntington’s disease, and premenstrual
dysphoric disorder.
Citalopram affects neurotransmitters, the chemical
transmitters within the brain. Neurotransmitters manufactured and released by nerves attached to adjacent nerves
and alter their activities. Thus, neurotransmitters are
considered the communication system of the brain. Many
experts believe that an imbalance among neurotransmitters

is the cause of depression. Citalopram works by preventing the uptake of serotonin by nerve cells after it has been
released. Such uptake is an important mechanism for
removing released neurotransmitters and terminating their
actions on adjacent nerves. The reduced uptake caused by
citalopram results in stimulation of the nerve cells by the
free serotonin in the brain(1).
A number of research describe the determination
of citalopram in biological fluids(2,3) and pharmaceutical
formulation(4,5) by several methods. However, potentio-

* Author for correspondence. E-mail:ganjali@khayam.ut.ac.ir
Figure 1. Chemical structure of citalopram.
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metric detection based on ion–selective electrodes (ISEs)
offers the advantages of speed and ease of preparation
and procedures, relatively fast response, reasonable selectivity thorough judicious choice of the membrane active
materials, wide linear dynamic range, and low cost.
These characteristics have inevitably led to the preparation of numerous sensors for several ionic species, and
the list of available electrodes has grown substantially
over the past years (6).
Computational chemistry and molecular modeling
play important roles in the modern drug discovery(7-11).
Computational work is also valuable in the drug development, where medium-sized organic pharmaceuticals
are selected as candidates and made in larger quantities.
Instead of modeling interactions with macromolecules,
the prediction of molecular properties for small molecules is more essential in the development stage.
The strength of binding usually correlates with the
target molecules tendency to the ligand. Several energy
contributions may be responsible for the binding, with
electrostatic interactions playing a dominant role in the
process, at least in sequence preferences and the target
molecules positioning(12,13).
No studies to date in the literature have used computational methods to evaluate drug selective ligands by
electronic properties. The lack of work in this area is
probably due to the inherent difficulties associated with
calculations on a Drug-Ligand complex, including the
lack of parameters for semi-empirical or empirical methods even though the numbers of atoms in typical drug
complexes indicate the use of these lower level calculations would be appropriate.
Furthermore, literature survey shows no reported
sensor for citalopram. In this work, we report a membrane
sensor based on an ion-pair to determine citalopram in its
formulation samples and urine with a Nernstian response
over a relatively wide working range. Also, in this study
we used DFT (Density Functional Theory) atomic population analysis to measure a Ligand-drug complexing by
examining the ability of the ligand to change in atomic
charges and bond length of drug. This method was found
to be simple, accurate and precise and can be used as a
detector for HPLC(14-17).

EXPERIMENTAL SECTION

II. Materials and Reagents
The necessary chemicals (of analytical reagent grade)
were: high-molecular weight polyvinylchloride (PVC)
(Fluka Co., USA), sodium tetraphenylborate (NaTPB),
acetophenon (AP), dibutyl phthalate (DBP), nitrobenzene
(NB), nitrophenyloctyl ether (o-NPOE) and tetrahydrofuran (THF) (Merck Co., Germany). All materials were of
the highest available purity without further modification.
Citalopram hydrobromide and its tablets were obtained
from different local pharmaceutical manufacturers.
III. Preparation of Ion-pair Compound
Ion-pair compound of citalopram-tetraphenylborate
(CP-TPB) was prepared as follows: about 20 mL of 0.01
M solution of citalopram hydrobromide was mixed with
20 mL of 0.01 M solution of tetraphenylborate under stirring. The resulting precipitate was filtered, washed with
water and dried(18-20).
IV. Preparation of the Electrodes
The general procedure to prepare the PVC membrane
was as follow: different amounts of the ion-pair along with
appropriate amounts of PVC, plasticizer and additive were
dissolved in tetrahydrofuran (THF), and the solution was
mixed well. The resulting mixture was transferred into a
glass dish of 2 cm diameter. The solvent was evaporated
slowly until an oily concentrated mixture was obtained.
A pyrex tube (3-5 mm o.d.) was dipped into the mixture
for about 10 s so that a transparent membrane of about 0.3
mm in thickness was formed. The tube was then pulled
out from the mixture and kept at room temperature for
about 10 h. Afterwards, the tube was filled with an internal filling solution (1.0×10 -3 M citalopram hydrobromride).
The electrode was finally conditioned for 24 h by soaking
in a 1.0×10 -3 M citalopram hydrobromide solution(21-25).
V. Standard Citalopram Solutions
A stock standard solution of 0.02 M citalopram
hydrobromide was prepared by dissolving 0.405 g of pure
drug in 100 mL of distilled water. The working solutions
(1×10 -6 to 1×10 -2 M) were prepared by appropriately diluting of the stock solution with water.

I. Apparatus

VI. The emf Measurements

The glass cell, where the citalopram-selective electrode was placed, consisted of an R684 model Analion Ag/
AgCl double junction reference electrode as the internal
reference electrode and a double-junction saturated calomel electrode (SCE, Philips, Netherlands). The cell chamber was filled with an ammonium nitrate solution and both
electrodes were connected to a Corning ion analyzer with
a 250 pH/mV meter with ± 0.1 mV precision.

The following cell was assembled for the conduction
of the emf (electromotive force) measurements:
Ag-AgCl | internal solution, 1×10 -3 M citalopram.
HBr | PVC membrane | sample solution | Hg-Hg 2Cl 2 , KC1
(satd.)
These measurements were preceded by the calibration of the electrode with several citalopram.HBr solutions (working solutions).
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VII. Computational Methods
Calculations on the isolated molecules and molecular complexes were performed within GAUSSIAN 98
package (26). Each species was initially optimized with
the parametric method three (PM3)(27-29) and then the
optimized structures were again optimized with density
functional theory using the 6-31G* basis set. Full geometry optimizations and frequency calculations were
performed and each species was found to be minimal
amounts without any negative values in the frequency
calculation. The calculations gave internal energies at 0
K. In order to obtain gas phase free energies at 298.15 K,
it was necessary to calculate the zero-point energies and
thermal corrections together with entropies to convert the
internal energies to Gibbs energies at 298.15 K(27,28).
Frequency calculations on these structures verified that they were true minima and provided the necessary thermal corrections to calculate H (Enthalpy) and
G (Gibbs free energy). Finally, full optimization and
frequency calculation for each species were performed
with the DFT/6-31G*(30,31).
Additional one-electron properties (dipole moment,
polarizability, energies of the frontier molecular orbital)
were also determined at the B3LYP/6-31G* level (Becke,
three-parameter, Lee-Yang-Parr)(30,31). For the charged
species, the dipole moment was derived with respect to
their mass center since the non-neutral molecules’ calculated dipole moment depended on the origin of the coordinate system.
The stabilization energies of the selected complexes were determined using the DFT calculations and
estimated with a recently introduced method based on
the combination of the approximate tight-binding DFTB
(Density Functional based Tight Binding) with the empirical dispersion energy. The DFT methods are known to
be inherently very deficient for stacking interactions, as
they ignore the dispersion attraction(32-34). As a consequence, their enlargement by an empirical dispersion
terms allows the DFT method to be used for the evaluation of the molecular complexes. Note that the interaction energies were obtained as the difference between the
complex energy and the combined energies of the molecules in isolation(35).

RESULTS AND DISCUSSION
I. Computational Study
Molecular parameters are controlled by the molecular geometry; therefore, geometry optimization is the
most important step for the calculation of the interaction
energy. The optimized geometries and numeration of the
atoms of the studied molecules, i.e. L1 for NaTPB, L2 for
KTpClPB, Drug for CP, Drug-L1 for CP-TPB and Drug-L2
for CP-TpClPB, are presented in Figs. 2 to 6, respectively.

Figure 2. The full optimized structure of L1.

Figure 3. The full optimized structure of L2.

To obtain a clue on citalopram tendency for L1 and
L2 as potential ionophores, DFTB calculations (B3LYP/631G*) were carried out. The pair wise interaction energy
ΔEA–B between molecules A (L1 or L2) and B (the drug)
was estimated as the difference between the energy of
the formed complex and that of the isolated partners.
The interaction energies were corrected for the basis set
superposition error using the counterpoise method (36,37).
ΔEA–B = EA−B − EA − EB
which was found to be -67.716 and -52.007 Kcal/mol
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Figure 4. The full optimized structure of CP.

Figure 5. The full optimized structure of L1-CP complex.

for ΔEL1 and ΔEL2 , respectively. This result indicated
that L1 is a more appropriate ionophore for citalopram
sensor in comparison to L2 due to its higher interaction
energy. The main discussions are going to be on L1-CP
interaction afterward.
Results in Table 1 (the most noticeable Mulliken
atomic charge changes) show that electrostatic interactions are the most dominant force between the drug

and L1. Furthermore, charge changes in the ion pairs
are localized on specific atoms that interact with each
molecule (38,39). Hetero atoms (N, O and F) significant
charge changes confirm hydrogen bonding and electrostatic interactions effective role in ion pair formation, e.g.
N21 (from -0.216 to -0.223), N18 (from -0.321 to -0.188),
O12 (from -0.295 to -0.256), F24 (from -0.140 to -0.100),
Moreover, significant changes were seen for carbon and
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Figure 6. The full optimized structure of L2-CP complex.

Table 1. Significant computed atomic charges and bond length for citalopram and L1 before and after the complex formation

Atom No.

Some important atomic charges
(unit of electric charge)

Atom No.

Some important atomic charges
(unit of electric charge)
CP

CP-L1

R(7,12)

1.450

1.450

-0.256

R(11,12)

1.448

1.444

0.005

0.068

R(17,18)

1.182

1.157

N18

-0.321

-0.188

R(20,21)

1.544

1.522

C20

0.001

-0.007

R(20,39)

1.091

1.092

N21

-0.216

-0.223

R(21,22)

1.520

1.508

C22

-0.080

-0.087

R(21,23)

1.520

1.414

C23

-0.080

-0.082

F24

-0.140

-0.100

R(21,25)

1.042

1.096

H25

0.282

0.300

R(22,41)

1.0895

1.088

No.

L1

L1-CP

R(23,44)

1.089

1.088

C4

-0.068

-0.075

Bond lengths

L1

L1-CP

B7

0.232

0.027

R(4,7)

1.643

1.656

C8

-0.068

-0.075

R(7,8)

1.643

1.655

C14

-0.068

-0.077

R(7,14)

1.643

1.657

C50

-0.068

-0.073

R(7,20)

1.643

1.656

HOMO (eV)

-4.52

2.77 for L1

LUMO (eV)

3.12

10.94 for L1

CP

CP-L1

C9

-0.072

-0.001

O12

-0.292

C17

Bond lengths (Å)
R(1,24)

1.357

1.355
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hydrogen atoms, especially for H25 (from 0.282 to 0.300).
In L1, which is connected to carbon atoms, remarkable
atomic charge changes are seen for boron (from 0.232
to 0.027). Additionally, the bond lengths also changed
as a result of ion pair formation (Table 1). According to
Table 1, the maximum bond length change occurred in
N21-H25 drug which indicates the interaction between
the hydrogen (the most positive charge) and L1 (negative
charge). Other bond length changes are localized on N21,
(N21-C20 and N21-C23 and N21-C22). For L1, B7-C4
and B7-C20 are the most significant bond length changes.
High values of polarizability (155.772 and 144.088
for L1 and drug, respectively) have proven L1’s effective role in the interactions between L1 and the drug. On
the other hand, the low values of dipole-dipole interactions (especially for that of L1 = 0.0 and for drug = 0.6D)
show that the dipole-dipole interactions do not play a
significant role on interactions existing among L1 and the
studied drug. As for the electrostatic interactions, atom
charges are delocalized on L1 while they are localized on
the drug (Table1).
The highest occupied molecular orbital (HOMO)
and the lowest unoccupied molecular orbital (LUMO)
for L1 and drug were calculated at the B3LYP/6-31G(d)
level (Table 1). The eigen values of LUMO and HOMO
and their energy gap reflect the chemical activity of the
molecule. LUMO as an electron acceptor shows the ability to obtain an electron, while HOMO as an electron
donor represents the ability to donate an electron. The
results in Table 1 illustrate the charge transfer interaction
between L1 and drug, because the HOMO energy of L1
was close to that of LUMO energy of the drug.
II. Membrane Composition Influence and Selection
Because the sensitivity and selectivity degree of
an ion-pair based electrode is greatly related to the
membrane ingredients, the membrane composition influence on the potential responses of the citalopram sensor
was determined. The operating characteristics of the
ISEs can be significantly modified by changing the rela-

tive proportions of the electrode membrane components.
The main components of an electrode membrane of this
type are PVC matrix, the plasticizer and the ion-pair.
Each membrane component plays a special role in the
membrane function(40-45).
The plasticizer mainly acts as a fluidizer, allowing
homogeneous dissolution and diffusional mobility of
the ion-pair inside the membrane. The nature and/or the
amount of the plasticizer must be properly controlled to
minimize the electrical asymmetry of the membrane and
to limit fouling of the sensor. The nature of the plasticizer has a marked influence on the response slope, linear
domain and selectivity of the PVC membrane electrodes.
Here, many plasticizer types were tested, namely acetophenon (AP), dibutyl phthalate (DBP), nitrobenzene (NB)
and nitrophenyloctyl ether (o-NPOE), as listed in Table
2. In this study, DBP was chosen for the sensor construction. It had the lowest dielectric constant and provided
an effective linear range and a lower detection limit due
to the better extraction of the citalopram in the organic
layer (46-48).
As it can be seen from Table 2, the absence of the
ion-pair in the membrane resulted a very poor response
(membrane no. 7), suggesting significance of the ion-pair.
As a conclusion, membrane no. 2 with the composition of
30% PVC, 4% ion-pair, and 66% DBP was the optimum
one for the sensor design.
III. Calibration Graph and Statistical Data
The measuring range of an ion-selective electrode
included the linear part of the calibration graph as shown
in Figure 7. Measurements could be performed in this
lower range, but noted that more closely spaced calibration points are required for more precise determinations.
For many electrodes the measuring range can extend
from 1 molar to 10 -6 or even 10 -7 molar concentrations.
According to another definition, the measurment range
of an ion-selective electrode is defined as the activity
range between the upper and lower detection limits (46-48).
In line with the membrane no. 2 performance, a calibra-

Table 2. Optimization of the membrane ingredients
Detection Limit (M)

Slope (mV/decade)

Ion-pair (% w)

Plasticizer (% w)

PVC (% w)

Membrane no.

-5

-2

52.7 ± 0.4

3

DBP, 67

30

1

7.9 × 10

-5

-2

1.0 × 10 -1.0 × 10

58.6 ± 0.3

4

DBP, 66

30

2

9.0 × 10-6

5.0 × 10-5 -1.0 × 10-2

1.0 × 10

-5
-6

Linear range (M)
1.0 × 10 -1.0 × 10

56.5 ± 0.3

6

DBP,64

30

3

-5

-2

41.2 ± 0.3

5

NB, 63

30

4

-5

-2

39.2 ± 0.2

5

NPOE, 63

30

5

8.2 × 10

-5

-2

1.0 × 10 -1.0 × 10

45.7 ± 0.4

5

AP, 63

30

6

3.0 × 10-4

6.0 × 10-4 -2.0 × 10-3

4.3 ± 0.2

-

DBP, 70

30

7

-5

1.0 × 10

-5

5.0 × 10

-6

1.0 × 10 -1.0 × 10
5.0 × 10 -1.0 × 10
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vs. pH behavior took place below and above the formerly
stated pH limits. In detail, the fluctuations above the pH
value of 5.5 might be justified by removing the positive
charge on the drug molecule. Fluctuations below the pH
value of 3.0 were caused by removal of the ion-pair in
the membrane.

100
80
60

E(mV)

40
20
0
-20

VI. Life-time Study

-40
-60
-80
-100

8

7

6

5

4

3

2

1

0

pCitalopram

Figure 7. Calibration curve of the citalopram membrane sensor
with the composition of membrane no. 2. The results are based on 8
measurements.

tion graph slope of 58.6 ± 0.3 mV/decade of the citalopram concentration and a standard deviation of ± 0.3
mV after eight replicate measurements. Also, electrode
with composition of membrane no. 2 presented a linear
response towards the citalopram.HBr concentration
from 1.0×10 -5 -1.0×10 -2 M of the citalopram.HBr solution
(Figure 7).
The detection limit was calculated from the intersection of the two extrapolated segments of the calibration
graph. In this work, the detection limit of the proposed
membrane sensor was 7.9×10 -6 mol/L which was calculated by extrapolating the two segments of the calibration
curve (Figure 7).
IV. Dynamic Response Time of the Citalopram-based
Sensor
Dynamic response time is the required time for the
sensor to reach values within ±1 mV of the final equilibrium potential, after successive immersions in the citalopram solutions. Its calculation involved the variation and
the recording of the citalopram concentration in a series
of solutions from 1.0×10 -5 to 1.0×10 -2 M. The sensor was
able to quickly reach its equilibrium response (~5 s) in
the whole concentration range.
V. pH Effect on the Electrode Response
To examine impact of pH on the electrode response,
the potential was measured at two specific concentrations
of the citalopram solution (1.0×10 -3 M and 1.0×10 -4 M)
from the pH value of 2.0 up to 12.0 (concentrated NaOH
or HCl solutions were employed for the pH adjustment).
The results showed that the potential remained constant
despite the pH change in the range of 3.0 to 5.5, which
indicates the applicability of this electrode in the specified pH range.
Relatively noteworthy fluctuations in the potential

The citalopram-selective electrode lifetime was
estimated with the calibration curve, periodical test of a
standard solution (1.0×10 -5 -1.0×10 -2 M, citalopram.HBr)
and calculation of its response slope.
For this estimation, four electrodes were employed
extensively (2 hour per day) for 10 weeks. After 8 weeks
of utilization, two changes were observed: a slight gradual decrease in the slope (from 58.6 ± 0.3 to 53.2 ± 0.4
mV/decade) and an increase in the detection limit (from
7.9×10 -6 M to 3.5×10 -5 M).
VII. Analytical Applications
(I) Recovery Test from the Citalopram Tablet
The proposed sensor was evaluated by measuring
the drug concentration in some pharmaceutical formulations. The recovery results are shown in Table 3. The
drug concentration was determined with the calibration
method. The results are in satisfactory agreement with the
labeled amounts. The RSD was equivalent to 2.0% with a
corresponding recovery percentage value of 99.86%.
(II) Recovery of Citalopram from Urine Samples
In order to investigate the applicability of the new
sensor to determination of drug in biological fluids, the
proposed sensor was applied to recover citalopram from
urine samples. Two milliliter of 10 -4 M citalopram solution was transferred into a 10 mL volumetric flask. After
addition of 2.5 mL of urine samples, the solution was
diluted to the mark with water. The citalopram content of
the solution was then determined by the proposed elec-

Table 3. Potentiometric determination of citalopram in pharmaceutical formulations
Labeled amount
(mg/tab.)

Found*
(mg/tab.)

Citalopram tablet, Bakhtar
Biochemistry

10

10.2 ± 0.3

Citalopram tablet, Sobhan Darou

10

9.9 ± 0.2

Citalopram tablet, Osveh

10

10.3 ± 0.4

Sample

* The results are based on triplicate measurements
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trode, using the calibration method. The recovery from
three replicate measurements was found to be 105.3%,
103.2% and 104.4%, respectively.
VIII. Validation of the Method
The linearity, limit of detection, selectivity, precision, accuracy, and ruggedness/robustness were the
parameters used for the method validation. As mentioned
before, the citalopram sensor was measured between
1×10 -5 and 1×10 -2 M. The calculated detection limit of the
sensor was 7.9×10 -6 M (3 µg/mL).

Table 4. Selectivity coefficients of various interfering compounds
for citalopram sensor
Interference

Log KMPM

Na+

-3.33

Cl−

-3.42

−

Br

-3.61

−

I

-3.75

CO32-

-2.80

NO3−

-3.21

2+

(I) Selectivity
Selectivity, which describes an ion-selective electrode’s specificity toward the target ion in the presence
of interfering ions, is the most important characteristic of
these devices. The potentiometric selectivity coefficients
of the citalopram sensor were evaluated by the matched
potential method (MPM)(48,49). The resulting values of
the selectivity coefficients are shown in Table 4. Note
that all selectivity coefficients are about 10 -3, suggesting
were interferences negligible in the performance of the
electrode assembly.
(II) Precision
Repeatability and reproducibility were investigated in order to assess precision of the technique. For the
repeatability monitoring, 8 replicate standard samples
in 3, 30, 300 µg/mL were measured. The mean concentrations were found to be 3.05, 30.7, 303.3 µg/mL with
respective RSD values of 1.6, 1.05, and 0.30%. Regarding the inter-day precision, the same three concentrations
were measured for three consecutive days, providing
mean citalopram concentrations of 3.04, 30.5, 303.6 µg/
mL and associated RSD values of 1.72, 1.02, and 0.27%,
respectively.
(III) Accuracy
The relevant error percentage and accuracy were
calculated in each case above. The resultant concentrations were 3.04 ± 0.02, 30.5 ± 0.4, and 303.6 ± 1.2 µg/mL
with relevant error percentages of 3.53, 1.34, and 0.33%,
respectively.
(IV) Ruggedness/Robustness
For ruggedness of the method a comparison was
performed between the intra- and inter-day assay results
for citalopram obtained by two analysts. The RSD values
for the intra- and inter-day assays of citalopram in the
cited formulations performed in the same laboratory
by the two analysts did not exceed 3.2%. On the other
hand, the robustness was examined while the parameter

Mg

-3.57
2-

HPO4

-3.15

Ca2+

-3.14

K+

-2.91

glucose

-2.53

histamine

-3.43

ammonium

-3.17

values (pH of the solution and the laboratory temperature
(changed slightly. Citalopram recovery percentages were
good under most conditions, not showing any significant
change when the critical parameters were modified.

CONCLUSIONS
In the present paper, types of interactions between
a drug and ligands were studied. Since the studied molecules were in the form of ions that resulted in ion pair
formation, DFTB method which also considers dispersion energies in addition to those calculated using DFT
was used for further investigations. These theoretical calculations help select appropriate ionophores and
also predict their selectivity for different drugs. After a
number of experiments involving the usage of CP-TPB
ion-pair complexes along with several plasticizers in the
membrane design, it was concluded that the citalopram
sensor yielded good analytical performance. Citalopram
sensor demonstrated an advanced performance with
a fast response time (~5 s), a lower detection limit of
7.9×10 -6 M and potential responses across the range of
1.0×10 -5 -1.0×10 -2 M. This sensor enabled the citalopram
determination in laboratory titrations and measurement
of the drug rate release from its formulation.
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